Professional Documents
Culture Documents
Pulmonary Alveolar Proteinosis
Pulmonary Alveolar Proteinosis
จานวนผู้ป่วยโดยประมาณในไทย : 100 คน
• Any type of PAP: survival from the date of diagnosis was 78%, 75% and 68% at 2, 5 and 10 years
• In Thailand, the probability of still being in follow-up. There were 19, 12, 4, and 1 patients at baseline, 5, 10,
and 15 years, respectively. The longest follow-up was 18 years in one patient. Five-year survival was 63% in 12
PAP patients who were followed for more than five years.
เอกสารอ้ างอิง
1. Borie R, Danel C, Debray M-P, Taille C, Dombret M-C, Aubier M, et al. Pulmonary alveolar proteinosis. Eur Respir
Rev. 2011 Jun 1;20(120):98.
2. Kaenmuang P, Navasakulpong A. Efficacy of whole lung lavage in pulmonary alveolar proteinosis: a 20-year
experience at a reference center in Thailand. J Thorac Dis Vol 13 No 6 June 2021 J Thorac Dis [Internet]. 2021
[cited 2021 Jan 1]; Available from: https://jtd.amegroups.com/article/view/52779
3. Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, et al. Pulmonary alveolar proteinosis. Nature
Reviews Disease Primers. 2019 Mar 7;5(1):16.
4. Kumar A, Abdelmalak B, Inoue Y, Culver DA. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical
approach. Lancet Respir Med. 2018 Jul;6(7):554-65.
5. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary
alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008;177:752-62.